Drug Shortage Report for MAR-GABAPENTIN
Report ID | 30475 |
Drug Identification Number | 02391473 |
Brand name | MAR-GABAPENTIN |
Common or Proper name | MAR-Gabapentin |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | DORMANT |
Active Ingredient(s) | GABAPENTIN |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 Capsule |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-09-10 |
Actual start date | 2017-09-10 |
Estimated end date | 2018-05-15 |
Actual end date | 2018-04-24 |
Shortage status | Resolved |
Updated date | 2018-07-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-23 | English | Compare |
v2 | 2017-11-23 | French | Compare |
v3 | 2018-04-24 | English | Compare |
v4 | 2018-04-24 | French | Compare |
v5 | 2018-04-25 | English | Compare |
v6 | 2018-07-06 | English | Compare |
v7 | 2018-07-06 | French | Compare |
Showing 1 to 7 of 7